{
  "patent_number": "US 20250129171",
  "country": "US",
  "title": "CAR T-Cells That Fight Ovarian and Prostate Cancer by Targeting LHR",
  "original_title": "Car t-cell therapy directed to lhr for the treatment of solid tumors",
  "summary": "This patent describes a new type of CAR T-cell therapy designed to fight ovarian and prostate cancers by specifically targeting the Luteinizing Hormone Receptor (LHR) protein found on cancer cells.",
  "what_it_does": "This patent describes a Chimeric Antigen Receptor (CAR) that specifically targets the Luteinizing Hormone Receptor (LHR) protein. This CAR is made up of several parts: an \"antigen binding domain\" from an anti-LHR antibody (using specific heavy and light chain variable regions, like SEQ ID NO.: 3 and 7), a \"hinge domain,\" a \"transmembrane domain,\" a \"costimulatory signaling region,\" and a \"CD3 zeta signaling domain\" (Claim 1). These CARs are then put into immune cells, typically T-cells or Natural Killer (NK) cells (Claim 8), making them into a targeted therapy. When these modified T-cells or NK cells encounter cancer cells that have LHR on their surface, they are designed to attack and inhibit the growth of those cancer cells (Claim 11, 13). For example, a patient with prostate cancer that expresses LHR could receive these modified T-cells to specifically target and destroy their tumor cells.",
  "what_it_does_not_cover": [
    "CAR T-cell therapies that target cancer proteins other than the Luteinizing Hormone Receptor (LHR).",
    "CAR T-cells that do not include all the specified components, such as a hinge domain, transmembrane domain, costimulatory signaling region, and CD3 zeta signaling domain.",
    "CAR T-cells where the antigen binding domain does not use the specific antibody sequences (SEQ ID NO.: 3 and 7) or sequences with at least 90% identity to them.",
    "Methods of treating cancers that do not express or overexpress the LHR protein.",
    "Traditional chemotherapy, radiation therapy, or surgical methods for cancer treatment."
  ],
  "filed": "2024-05-20",
  "granted": null,
  "expires": "2044-05-20",
  "status": "active",
  "holder": "University of Southern California",
  "holder_url": "https://patentbrief.org/company/university-of-southern-california",
  "inventors": [
    {
      "name": "Alan L. Epstein",
      "url": "https://patentbrief.org/inventor/alan-l-epstein"
    },
    {
      "name": "Peisheng Hu",
      "url": "https://patentbrief.org/inventor/peisheng-hu"
    },
    {
      "name": "Jacek K. Pinski",
      "url": "https://patentbrief.org/inventor/jacek-k-pinski"
    }
  ],
  "times_cited": 0,
  "tags": [
    "biotech",
    "pharmaceutical",
    "gene_editing",
    "oncology"
  ],
  "abstract": "Provided herein are novel anti-LHR chimeric antigen receptor (CAR), cells or compositions comprising the same, vector or plasmid encoding anti-LHR CAR, and methods for producing the same, or using the same for detecting or treating ovarian cancer or prostate cancer. Also provided herein are anti-LHR antibody, compositions comprising the same, nucleic acid sequence encoding the same, and a kit for detecting LHR.",
  "url": "https://patentbrief.org/patent/us/20250129171/car-t-cell-therapy-directed-to-lhr-for-the-treatment-of-solid-tumors",
  "markdown_url": "https://patentbrief.org/patent/us/20250129171/car-t-cell-therapy-directed-to-lhr-for-the-treatment-of-solid-tumors/md",
  "google_patents_url": "https://patents.google.com/patent/US20250129171",
  "relatedPatents": [
    {
      "patentNumber": "9328156",
      "countryCode": "US",
      "title": "How Genetically Modified T-Cells Attack Cancer",
      "url": "https://patentbrief.org/patent/us/9328156/use-of-chimeric-antigen-receptor-modified-t-cells-to-treat-cancer"
    },
    {
      "patentNumber": "20240165159",
      "countryCode": "US",
      "title": "Targeting Cancer with CAR T Cells Using a Chemical Tag",
      "url": "https://patentbrief.org/patent/us/20240165159/compositions-and-methods-for-car-t-cell-therapy"
    },
    {
      "patentNumber": "9481728",
      "countryCode": "US",
      "title": "How Genetically Modified T-Cells Fight CD19 Cancers",
      "url": "https://patentbrief.org/patent/us/9481728/compositions-and-methods-for-treatment-of-cancer"
    },
    {
      "patentNumber": "12600775",
      "countryCode": "US",
      "title": "Treating a Specific Lymphoma with Modified T Cells",
      "url": "https://patentbrief.org/patent/us/12600775/chimeric-antigen-receptor-t-cell-therapy"
    },
    {
      "patentNumber": "12735503",
      "countryCode": "US",
      "title": "Using Antibodies and CAR-T Cells to Fight MUC1-C Expressing Cancers",
      "url": "https://patentbrief.org/patent/us/12735503/anti-muc1-c-antibodies-and-car-t-structures"
    }
  ]
}